0

Coronary Risk Factors Collection
 181-200 of 1920 Articles
Editorials |  21 April 2009 FREE
Communicating Drug Benefits and Risks Effectively: There Must Be a Better Way
Jerry Avorn, MD; William H. Shrank, MD, MSHS
Ann Intern Med. 2009;150(8):563-564. doi:10.7326/0003-4819-150-8-200904210-00012
Articles |  7 April 2009
Effect of Varying Levels of Disease Management on Smoking Cessation: A Randomized Trial
Edward F. Ellerbeck, MD, MPH; Jonathan D. Mahnken, PhD; A. Paula Cupertino, PhD; et al.
Ann Intern Med. 2009;150(7):437-446. doi:10.7326/0003-4819-150-7-200904070-00003
Articles |  7 April 2009
Triple-Combination Pharmacotherapy for Medically Ill Smokers: A Randomized Trial
Michael B. Steinberg, MD, MPH; Shelley Greenhaus, RN, MPH; Amy C. Schmelzer, MS; et al.
Ann Intern Med. 2009;150(7):447-454. doi:10.7326/0003-4819-150-7-200904070-00004
Reviews |  7 April 2009
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Stanley Ip, MD; Alice H. Lichtenstein, ScD; Mei Chung, MPH; et al.
Ann Intern Med. 2009;150(7):474-484. doi:10.7326/0003-4819-150-7-200904070-00007
Editorials |  7 April 2009
The Future of Tobacco Treatment in the Health Care System
Nancy A. Rigotti, MD
Ann Intern Med. 2009;150(7):496-497. doi:10.7326/0003-4819-150-7-200904070-00011
Articles |  3 March 2009
Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection
Michael J. Silverberg, PhD, MPH; Wendy Leyden, MPH; Leo Hurley, MPH; et al.
Ann Intern Med. 2009;150(5):301-313. doi:10.7326/0003-4819-150-5-200903030-00006
Articles |  17 February 2009
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Mark J. Pletcher, MD, MPH; Lawrence Lazar, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Ann Intern Med. 2009;150(4):243-254. doi:10.7326/0003-4819-150-4-200902170-00005
Articles |  20 January 2009 FREE
Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3
Nina P. Paynter, PhD; Daniel I. Chasman, PhD; Julie E. Buring, ScD; et al.
Ann Intern Med. 2009;150(2):65-72. doi:10.7326/0003-4819-150-2-200901200-00003
Articles |  20 January 2009
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Karim El Harchaoui, MD; Benoit J. Arsenault, MSc; Remco Franssen, MD; et al.
Ann Intern Med. 2009;150(2):84-93. doi:10.7326/0003-4819-150-2-200901200-00006
Reviews |  20 January 2009
Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus
Marion L. Vetter, MD, RD; Serena Cardillo, MD; Michael R. Rickels, MD, MS; et al.
Ann Intern Med. 2009;150(2):94-103. doi:10.7326/0003-4819-150-2-200901200-00007
Articles |  6 January 2009
Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
David D. Dore, PharmD, PhD; Kate L. Lapane, PhD; Amal N. Trivedi, MD, MPH; et al.
Ann Intern Med. 2009;150(1):9-18. doi:10.7326/0003-4819-150-1-200901060-00004
Articles |  18 November 2008
Motivational Enhancement Therapy with and without Cognitive Behavior Therapy to Treat Type 1 Diabetes: A Randomized Trial
Khalida Ismail, BM BCh, PhD; Stephen M. Thomas, MB BS; Esther Maissi, MSc; et al.
Ann Intern Med. 2008;149(10):708-719. doi:10.7326/0003-4819-149-10-200811180-00005
Articles |  4 November 2008 FREE
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial
Ralf Nass, MD; Suzan S. Pezzoli, BA; Mary Clancy Oliveri, MS; et al.
Ann Intern Med. 2008;149(9):601-611. doi:10.7326/0003-4819-149-9-200811040-00003
Articles |  21 October 2008
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial
Gérald Simonneau, MD; Lewis J. Rubin, MD; Nazzareno Galiè, MD; et al.
Ann Intern Med. 2008;149(8):521-530. doi:10.7326/0003-4819-149-8-200810210-00004
Articles |  21 October 2008
Addition of Neutral Protamine Lispro Insulin or Insulin Glargine to Oral Type 2 Diabetes Regimens for Patients with Suboptimal Glycemic Control: A Randomized Trial
Katherine Esposito, MD, PhD; Miryam Ciotola, MD; Maria Ida Maiorino, MD; et al.
Ann Intern Med. 2008;149(8):531-539. doi:10.7326/0003-4819-149-8-200810210-00005
Reviews |  21 October 2008 FREE
Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes
Rehan Qayyum, MD; Shari Bolen, MD, MPH; Nisa Maruthur, MD, MHS; et al.
Ann Intern Med. 2008;149(8):549-559. doi:10.7326/0003-4819-149-8-200810210-00242
Editorials |  21 October 2008
Newer Insulins in Search of a Niche
Sachin Majumdar, MD; Eugene Barrett, MD, PhD
Ann Intern Med. 2008;149(8):586-588. doi:10.7326/0003-4819-149-8-200810210-00011
Articles |  2 September 2008
Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in Women
Christin Heidemann, DrPH, MSc; Qi Sun, MD, ScD; Rob M. van Dam, PhD; et al.
Ann Intern Med. 2008;149(5):307-316. doi:10.7326/0003-4819-149-5-200809020-00005
Ideas and Opinions |  5 August 2008
Against Diagnosis
Andrew J. Vickers, PhD; Ethan Basch, MD; Michael W. Kattan, PhD
Ann Intern Med. 2008;149(3):200-203. doi:10.7326/0003-4819-149-3-200808050-00010
Articles |  15 July 2008
Prehypertension during Young Adulthood and Coronary Calcium Later in Life
Mark J. Pletcher, MD, MPH; Kirsten Bibbins-Domingo, PhD, MD; Cora E. Lewis, MD; et al.
Ann Intern Med. 2008;149(2):91-99. doi:10.7326/0003-4819-149-2-200807150-00005
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)